Drugs.com Blog

The Official Drugs.com Blog

Q4 2012 Drug Sales Data Released: Abilify Overtakes Nexium as the Top Drug by Sales

February 7, 2013 By Carmen Fookes

The latest U.S. drug sales data have been released by Drugs.com. At the close of 2012, Otsuka’s antipsychotic Abilify overtakes AstraZeneca’s acid reducer Nexium and moves into the number one spot with over $1.47 billion in quarterly sales. Sales expanded for all five front-runners over the quarter, although none reached double-digit growth. There are no changes in the top selling pharmaceutical classes, which include antipsychotics, proton pump inhibitors, and statins.

View the data here…
https://www.drugs.com/stats/top100/sales

Filed Under: Business, Statistics

Recent Posts

  • Green Gold April 30, 2019
  • Worshipping The Wine (or Beer) God or Godess April 23, 2019
  • No Easy Fix To The Opioid Crisis January 15, 2019
  • 2018: The Year for Blockbusters. December 26, 2018
  • How do I get my doctor to listen to me? December 18, 2018

Categories

  • Business
  • Commentary
  • Media
  • Mobile
  • Patient Safety
  • Site Upgrades
  • Statistics
  • Uncategorized

Copyright © 2023 Drugs.com - Return to Drugs.com